Donald Trump Blames FDA ‘Deep State’ for Coronavirus Vaccine Delay

Donald Trump Blames FDA ‘Deep State’ for Coronavirus Vaccine Delay

The FDA did not respond to a request for comment on the president's Saturday tweets.

Peter Marks, the director of the Food and Drug Administration's Centre for Biologics Evaluation and Research, said he would resign if the agency pushed out an unproven coronavirus vaccine.

In a Saturday tweet tagging FDA Commissioner Stephen Hahn, the president accused the "deep state" of delaying approval on clinical trials for a coronavirus vaccine on objective to affect November's election.

"Let me assure you that we will not cut corners", he said.

Marks told Reuters he has not faced any political pressure and that the FDA would be guided by science alone. He added that such speculations "only undermines confidence in the public health system". More than 5.5 million people have contracted the virus in the United States, according to the latest data compiled by Johns Hopkins University.

Marks said he cannot stand by and see something ineffective - or probably unsafe - being handed out to the general public for a political agenda.

Anthony Fauci, the director of the National Institute of Allergy and Infectious Diseases (NIAID) said in July that he's "cautiously optimistic" that a vaccine will be available by the end of this year.

Offit, who is part of a group helping advise companies and the federal government on vaccine development, said the FDA is requiring companies to go through carefully designed phases of testing, including large Phase 3 trials created to test effectiveness and safety, to minimize the risk that a product given to healthy people causes harm. The FDA, drug companies, and researchers, on the contrary, are moving at an unprecedented pace to produce vaccines and other groundbreaking treatments in the hopes of curbing the coronavirus pandemic.

His funeral service took place at the White House.

Large-scale clinical trials of the leading vaccine candidates from Moderna, Pfizer and AstraZeneca were launched in recent weeks. Meanwhile, the current president is trying to balance between controlling the pandemic and maintaining economic health.

Earlier this year, the FDA gave emergency authorization for hospitals to use malaria drug hydroxychloroquine as a COVID-19 treatment after it had been touted by Trump. Historically, FDA officials such as Marks have the final say on medical items released to the public.

More than 100 million doses of a vaccine expectedly to be available before the end of the year and 500 million doses ready shortly thereafter, Trump said during a White House press briefing on August 14.

Related Articles